Castle Biosciences (CSTL) Institutional Ownership
13F filers reported holding 18.3% of Castle Biosciences (CSTL) shares as of Sep 30, 2026, across 74 filers.
- Held by 13F filers
- 18.3%
- Sep 30, 2026
- 13F filers
- 74
- quarter ended Sep 30, 2026
- 13F value
- $200.0M
- 5.6M shares
- Quarter's fund flow
- Mild accumulation
- 14 new · 6 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Juvenal Tobin W | Chief Commercial Officer | Disposed · Open-market sale | 2,828 | $35.04 | ↗ |
| Nov 9, 2026 | Juvenal Tobin W | Chief Commercial Officer | Disposed · Open-market sale | 3,288 | $32.67 | ↗ |
| Nov 2, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 7,555 | $36.01 | ↗ |
| Nov 2, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 2,816 | $36.01 | ↗ |
| Nov 2, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 2,393 | $36.01 | ↗ |
| Nov 2, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 1,025 | $36.81 | ↗ |
| Nov 2, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 382 | $36.81 | ↗ |
| Nov 2, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 325 | $36.81 | ↗ |
| Oct 28, 2026 | Juvenal Tobin W | Chief Commercial Officer | Disposed · Open-market sale | 1,237 | $35.58 | ↗ |
| Oct 28, 2026 | Juvenal Tobin W | Chief Commercial Officer | Disposed · Open-market sale | 5,341 | $36.62 | ↗ |
| Oct 26, 2026 | Juvenal Tobin W | Chief Commercial Officer | Disposed · Open-market sale | 3,288 | $33.08 | ↗ |
| Oct 19, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 8,580 | $31.91 | ↗ |
| Oct 19, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 3,198 | $31.91 | ↗ |
| Oct 19, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 2,718 | $31.91 | ↗ |
| Oct 12, 2026 | Juvenal Tobin W | Chief Commercial Officer | Disposed · Open-market sale | 3,288 | $33.64 | ↗ |
| Oct 5, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Acquired · Option exercise | 8,165 | $2.39 | ↗ |
| Oct 5, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 8,580 | $35.57 | ↗ |
| Oct 5, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 3,198 | $35.57 | ↗ |
| Oct 5, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Open-market sale | 2,718 | $35.57 | ↗ |
| Oct 5, 2026 | MAETZOLD DEREK J | Pres. & Chief Exec. Officer | Disposed · Option exercise | 8,165Stock option (right to buy) | — | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Castle Biosciences do institutions hold?
13F filers reported holding 18.3% of Castle Biosciences' shares as of Sep 30, 2026, across 74 filers.
How many 13F filers hold Castle Biosciences?
Castle Biosciences was held by 74 13F filers as of Sep 30, 2026.
Not investment advice.

